Inhibition of syndecan-1 expression and function in oral cancer cells

Oncology Reports

Volumn 20, Issue 6, 2008, Pages 1353-1357

  Muramatsu, Takashi ^a   Saitoh, Masato ^b   Ro, Yasufumi ^a   Uekusa, Tomoko ^a   Iwamura, Eri ^a   Ohta, Kazumasa ^c   Kohno, Yohko ^d   Abiko, Yoshihiro ^b   Shimono, Masaki ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Invasion; Oral cancer; Squamous cell carcinoma; Syndecan 1

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; SYNDECAN 1; COLLAGEN; LAMININ; MATRIGEL; PROTEOGLYCAN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUTH CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL MOTION; CHEMISTRY; DRUG COMBINATION; DRUG SCREENING; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; MOUTH TUMOR; PROGNOSIS; TIME; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MODELS, BIOLOGICAL; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; PROTEOGLYCANS; RNA, SMALL INTERFERING; SYNDECAN-1; TIME FACTORS; TRANSFECTION;

EID: 59249090041     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000151     Document Type: Article

References (31)

1. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: 2001 Cancer statistics. CA Cancer J Clin 51: 15-36, 2001.
2. Takes RP, Baatenburg de Jong RJ, Schuuring E, Hermans J, Vis AA, Litvinov SV and van Krieken JH: Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123: 412-419, 1997.
3. Takes RP, Baatenburg De Jong RJ, Alles MJ, Meeuwis CA, Marres HA, Knegt PP, De La Riviere GB, De Wilde PC, Mooi WJ, Hermans J and Van Krieken JH: Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 128: 512-518, 2002.
4. Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, Kent R, Donoff RB, Todd R, Yung CM, Warrington JA and Wong DT: Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20: 6196-6204, 2001.
5. Macabeo-Ong M, Shiboski CH, Silverman S, Ginzinger DG, Dekker N, Wong DT and Jordan RC: Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol 39: 638-647, 2003.
6. Roskelley CD, Srebrow A and Bissell MJ: A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol 7: 736-747, 1995.
7. Inki P, Stenback F, Talve L and Jalkanen M: Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 139: 1333-1340, 1991.
8. Lester BR and McCarthy JB: Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev 11: 31-44, 1992.
9. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL and Lose EJ: Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8: 365-393, 1992.
10. Koda JE and Bernfield M: Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils. J Biol Chem 259: 11763-11770, 1984.
11. Saunders S and Bernfield M: Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol 106: 423-430, 1988.
12. Inki P, Stenback F, Grenman S and Jalkanen M: Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol 172: 349-355, 1994.
13. Rintala M, Inki P, Klemi P, Jalkanen M and Grenman S: Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol 75: 372-378, 1999.
14. Mikami S, Ohashi K, Usui Y, Nemoto T, Katsube K, Yanagishita M, Nakajima M, Nakamura K and Koike M: Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 92: 1062-1073, 2001.
15. Inki P and Jalkanen M: The role of syndecan-1 in malignancies. Ann Med 28: 63-67, 1996.
16. Inki P, Joensuu H, Grenman R, Klemi P and Jalkanen M: Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 70: 319-323, 1994.
17. Ro Y, Muramatsu T, Shima K, Yajima Y, Shibahara T, Noma H and Shimono M: Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue. Int J Oral Maxillofac Surg 35: 252-277, 2006.
18. Abiko Y, Okumura K, Ohuchi T, Konishi T, Kanazawa M and Kaku T: Basaloid-squamous cell carcinoma of the floor of the mouth: characterization of a cell line. J Oral Pathol Med 26: 367-370, 1997.
19. Muramatsu T, Shima K, Ohta K, Kizaki H, Ro Y, Kohno Y, Abiko Y and Shimono M: Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides. Cancer Lett 217: 87-95, 2005.
20. Ohtsuka W, Ohta K, Isshiki Y and Kizaki H: Quantitative analysis of osteopontin gene expression using a real time reverse transcription-polymerase chain reaction assay. J Hard Tissue Biol 9: 47-55, 2000.
21. Shima K, Muramatsu T, Abiko Y, Yamaoka Y, Sasaki H and Shimono M: Connexin 43 transfection in basaloid squamous cell carcinoma cells. Oncol Rep 16: 285-288, 2006.
22. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Takamori K, Igawa K, Yoshida M, Fukuyama H, Takahashi T and Sakoda S: Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma. J Oral Pathol Med 35: 301-306, 2006.
23. Senger DR, Asch BB, Smith BD, Perruzzi CA and Dvorak HF: A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 302: 714-715, 1983.
24. Senger DR and Perruzzi CA: Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells. Cancer Res 45: 5818-5823, 1985.
25. Kurokawa H, Matsumoto S, Murata T, Yamashita Y, Tomoyose T, Zhang M, Fukuyama H and Takahashi T: Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med 32: 513-521, 2003.
26. Su G, Blaine SA, Qiao D and Friedl A: Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J Biol Chem 282: 14906-14915, 2007.
27. Kaushal GP, Xiong X, Athota AB, Rozypal TL, Sanderson RD and Kelly T: Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9. Br J Haematol 104: 365-373, 1999.
28. Liebersbach BF and Sanderson RD: Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem 269: 20013-20019, 1994.
29. Reiland J, Sanderson RD, Waguespack M, Barker SA, Long R, Carson DD and Marchetti D: Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 279: 8047-8055, 2004.
30. O-charoenrat P, Rhys-Evans PH and Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813-820, 2001.
31. Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S, Nakamura S and Shirasuna K: Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17: 315-323, 1999.